<?xml version="1.0" encoding="UTF-8"?>
<ref id="B6-antibodies-08-00023">
 <label>6.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Emmadi</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Boonyaratanakornkit</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Selvarangan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Shyamala</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Zimmer</surname>
    <given-names>B.L.</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Bryant</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Schutzbank</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Schoonmaker</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Amos Wilson</surname>
    <given-names>J.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays</article-title>
  <source>J. Mol. Diagn.</source>
  <year>2011</year>
  <volume>13</volume>
  <fpage>583</fpage>
  <lpage>604</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jmoldx.2011.05.011</pub-id>
  <?supplied-pmid 21871973?>
  <pub-id pub-id-type="pmid">21871973</pub-id>
 </element-citation>
</ref>
